Your browser doesn't support javascript.
loading
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
Scucchi, L; Neri, B; Sarmati, L; Mossa, M; Sena, G; Massoud, R; Petruzziello, C; Musumeci, M; Marafini, I; Calabrese, E; Lolli, E; Bernardini, S; Andreoni, M; Monteleone, G; Biancone, L.
Affiliation
  • Scucchi L; Department of Systems Medicine, Unit of Gastroenterology, University of Rome "Tor Vergata", Rome, Italy. biancone@med.uniroma2.it.
Eur Rev Med Pharmacol Sci ; 25(5): 2418-2424, 2021 Mar.
Article in En | MEDLINE | ID: mdl-33755981
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2021 Document type: Article Affiliation country: Italia